TAS102

trifluridine/tipiracil

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS102, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer [Phase 2]